Brought to you by 
Medtronic buys MacroPore's CMF/N product lines for $21mm
07 Dec 2022
Executive Summary
Medtronic will buy all of MacroPore Biosurgery's (bioresorbable surgical implants) craniofacial/neurosurgical (CMF/N) fixation product-line assets for up to $21mm in cash.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Medtronic buys MacroPore's CMF/N product lines for $21mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice